Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 449.00
Bid: 444.00
Ask: 454.00
Change: 22.00 (5.15%)
Spread: 10.00 (2.252%)
Open: 444.00
High: 449.00
Low: 444.00
Prev. Close: 427.00
SAG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Oct 2020 07:00

RNS Number : 7080B
Science Group PLC
12 October 2020
 

 

 

 

 

12 October 2020

 

 

 

 

Science Group plc

(the "Group" or "Science Group")

 

 

Trading Update

 

Science Group announces that, following its trading update on 10 September 2020, revenue across the Group has continued to be at the higher end of the Board's expectations. In particular, the performance of Frontier is noteworthy in terms of both revenue and, due to an enhanced product mix, an improved operating margin. While the Board is using the opportunity to increase investments in the operating businesses, it is now apparent that the Group's adjusted operating profit for the year ended 31 December 2020 will exceed the Group's expectations as set out at the start of the year.

 

Frontier Smart Technologies

 

The acquisition of Frontier was completed one year ago this week. The restructuring and integration programme was executed rapidly and, in hindsight, would have been very challenging if it had not been completed before the outbreak of the pandemic. While the business was disrupted by Covid-19 in the first half of the year, demand for Frontier products has continued the recovery seen in the early summer, with shipments in 2020 now constrained by materials supply and orders booked for shipments in early 2021 now approaching 50% of the first quarter forecast.

 

The benefit of this uptick in demand is enhanced by an increasing proportion of SmartRadio modules (combined DAB, Internet Radio and music/podcast streaming services) in the product mix which have a higher average selling price than DAB-only modules. It is unclear whether this is a longer term trend at this stage, although Smart Radio sell through can be validated by tracking the quantity of first-time connections to the Nuvola IoT infrastructure and the data obtained supports the view of market growth in this sub-sector since mid-April.

 

As a result, after many years of losses, for the year to 31 December 2020 it is now anticipated that Frontier will slightly exceed the revenue plan set out at the start of the year and operating margins for the year are now anticipated to be broadly in line with the rest of the Group. In summary, Frontier has exceeded the Board's expectations in its first year post-acquisition.

 

Employee Appreciation and Charitable Donations

 

In achieving such a strong performance in this challenging year, the employees of Science Group have demonstrated their resilience, commitment and determination. The Board expresses its gratitude for this dedication and has awarded a one-off bonus of £500 to all eligible, permanent employees (pro-rated for part-time staff and localised for employees outside the UK).

 

In addition, early in the pandemic, the Board recognised the potential impact on some sectors of society and provided support to local food banks. Unfortunately, as we enter winter, Covid-19 remains firmly established and charitable sector fund raising continues to be very severely constrained. In light of the Group's successful financial performance, the Board has decided to increase the Group's charitable donations in 2020 to further support local communities in these difficult times.

 

2021 Outlook

 

The global economic environment remains unpredictable and the future will be subject to the effects of Covid-19, Brexit and the US Presidential election. Realistically it is impossible to incorporate such a combination of factors into a business plan. The Board will therefore continue its prudent operating model, making investments when financial results permit, and maintaining its primary focus on cash flow. This model, which is consistently implemented in every acquisition, has delivered resilient performance over the past decade, even during the pandemic .

 

Science Group also benefits from its strong balance sheet including gross cash (excluding client held funds) at 30 September 2020 of £25.0 million and net funds of £8.2 million, with the debt secured on the Group's substantial freehold property (office and laboratory) assets. This capital base enables the Board to continue to explore acquisition opportunities although, as always, there can be no certainty that any acquisitions will be completed.

 

 

 

 

End

 

Science Group plc

 

Martyn Ratcliffe, Chairman

Tel: +44 (0) 1223 875 200

Rebecca Archer, Finance Director

www.sciencegroup.com

 

 

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)

 

Nick Adams, Alex Price

Tel: +44 (0) 20 7710 7600

 

 

Liberum Capital Limited (Joint Broker)

 

Neil Patel, Cameron Duncan

Tel: +44 (0) 20 3100 2000

 

 

 

 

 

 

 

 

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation (No 596/2014). The person responsible for this announcement is Rebecca Archer, Finance Director.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUAUBRRRURAAA
Date   Source Headline
28th Nov 201112:40 pmRNSBlocklisting Application
26th Oct 20112:30 pmRNSGrant of Share Options
29th Sep 20117:30 amRNSContract Win
28th Sep 20117:00 amRNSDirectorate Change
21st Sep 20117:00 amRNSChange of Adviser
25th Jul 20117:00 amRNSInterim Results
7th Jul 20117:00 amRNSTrading Update
16th May 201110:15 amRNSResult of AGM
16th May 20117:00 amRNSAGM Trading Update
20th Apr 201111:09 amRNSPosting of Documents and Notice of AGM
28th Mar 201110:59 amRNSDirector Dealing
4th Mar 20114:27 pmRNSHolding(s) in Company
28th Feb 20117:00 amRNSFinal Results
15th Feb 20117:00 amRNSNotice of Results
11th Jan 20117:00 amRNSPre-Close Trading Update
16th Dec 20102:06 pmRNSHolding(s) in Company
17th Nov 201010:06 amRNSDirector Dealing
11th Oct 20107:00 amRNSTrading and Business Update
28th Sep 20104:52 pmRNSHolding(s) in Company
28th Sep 20104:50 pmRNSHolding(s) in Company
14th Sep 20107:00 amRNSHolding(s) in Company
27th Aug 20108:51 amRNSDirector Dealing
5th Aug 20107:00 amRNSGrant of Options
2nd Aug 20107:00 amRNSBoard Changes
21st Jul 20107:00 amRNSInterim Results
16th Jul 201010:02 amRNSNotice of Interim Results
12th Jul 20109:18 amRNSHolding(s) in Company
5th Jul 20107:00 amRNSPre-Close Trading Update
18th Jun 20103:08 pmRNSPosting of Annual Report
17th Jun 20103:55 pmRNSHolding(s) in Company
8th Jun 20101:15 pmRNSHolding(s) in Company
4th Jun 201011:43 amRNSResult of General Meeting & Directors' Shareholdng
20th May 20102:05 pmRNSResult of AGM
20th May 20107:00 amRNSAGM Statement
18th May 20107:00 amRNSPlacing and Notice of General Meeting
23rd Apr 20103:34 pmRNSNotice of AGM
15th Apr 20105:07 pmRNSBoard Changes
15th Apr 20104:45 pmRNSLevel of Acceptances and Lapse of Offer
15th Apr 20108:53 amRNSEPT Disclosure
12th Apr 20108:45 amRNSEPT Disclosure
7th Apr 20103:48 pmRNSResponse to Mandatory Offer and Directorate Change
31st Mar 20109:08 amRNSEPT Disclosure
30th Mar 20109:16 amRNSEPT Disclosure
29th Mar 20107:00 amRNSOffer Rejection
25th Mar 20104:23 pmRNSOffer Document Posted
24th Mar 201010:03 amRNSEPT Disclosure
23rd Mar 20103:35 pmRNSHolding in Company
23rd Mar 201011:45 amRNSRule 2.10 Announcement
23rd Mar 20107:00 amRNSRule 2.5 Announcement
18th Feb 20107:00 amRNSFinal Results - Part 2

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.